Visfatin is secreted into the breast milk and is correlated
with weight changes of the infant after the birth

J 2012

Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth

BIENERTOVÁ VAŠKŮ, Julie; Petr BIENERT; Filip ZLÁMAL; Josef TOMANDL; Marie TOMANDLOVÁ et al.

Základní údaje

Originální název

Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth

Název česky

Visfatin je secernován do mateřského mléka a koreluje s hmotnostními změnami kojence po porodu

Autoři

BIENERTOVÁ VAŠKŮ, Julie; Petr BIENERT; Filip ZLÁMAL ; Josef TOMANDL ; Marie TOMANDLOVÁ; Zuzana DOSTÁLOVÁ a Anna VAŠKŮ

Vydání

Diabetes Research and Clinical Practice, Ireland, Elsevier Ireland, 2012, 0168-8227

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30202 Endocrinology and metabolism

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.741

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/12:00059030

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.1016/j.diabres.2011.06.009

UT WoS

000305281100024

Klíčová slova česky

visfatin; mateřské mléko; tuková tkáň; hmotnost kojence

Klíčová slova anglicky

visfatin; breast milk; adiposity; infant weight

Příznaky

Mezinárodní význam

Změněno: 5. 10. 2012 12:46, Mgr. Michal Petr

Anotace

ORIG CZ

V originále

Visfatin is a recently identified adipokine with numerous metabolic and immunoregulatory properties that has been implicated in the regulation of the white adipose tissue (WAT) and significant changes in visfatin levels were reported during pregnancy. The aim of the study was to investigate dynamics of visfatin levels in maternal serum and human breast milk during a 180-d period after the delivery. Breast milk and venous blood samples were obtained from 24 healthy lactating women with uncomplicated, physiological pregnancy and appropriate- for-gestational age neonates and serum–milk sample duos were collected at the time of birth, at the 1–3, 12–14, 28–30, 88–90 and 178–180 postpartum. Our study demonstrates that (1) visfatin is abundantly secreted into breast milk in humans, reaching approx. 100x higher concentrations compared to maternal serum; (2) visfatin concentrations in maternal serum show significant variations after the delivery and (3) visfatin concentration in colostrum could be used for prediction of the subsequent weight development (less/more severe weight loss during first 3 days after the birth) of the infant. Our data suggest that visfatin could play an important role in regulation of adiposity of the infatn after the birth.

Česky

První dosud publikovaná studie popisující uvolňování visfatinu do mateřského mléka během celého 180-denního poporodního období. Dále demonstrujeme, že hladina visfatinu v mateřském mléce může být použita pro predikci hmotnostního vývoje kojence v časném poporodním období.

Citovat

BIENERTOVÁ VAŠKŮ, Julie; Petr BIENERT; Filip ZLÁMAL; Josef TOMANDL; Marie TOMANDLOVÁ; Zuzana DOSTÁLOVÁ a Anna VAŠKŮ. Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth. Diabetes Research and Clinical Practice. Ireland: Elsevier Ireland, 2012, roč. 96, č. 3, s. 355-361. ISSN 0168-8227. Dostupné z: https://doi.org/10.1016/j.diabres.2011.06.009.

@article{945143,
   author = {Bienertová Vašků, Julie and Bienert, Petr and Zlámal, Filip and Tomandl, Josef and Tomandlová, Marie and Dostálová, Zuzana and Vašků, Anna},
   article_location = {Ireland},
   article_number = {3},
   doi = {https://doi.org/10.1016/j.diabres.2011.06.009},
   keywords = {visfatin; breast milk; adiposity; infant weight},
   language = {eng},
   issn = {0168-8227},
   journal = {Diabetes Research and Clinical Practice},
   title = {Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth},
   volume = {96},
   year = {2012}
}

TY  - JOUR
ID  - 945143
AU  - Bienertová Vašků, Julie - Bienert, Petr - Zlámal, Filip - Tomandl, Josef - Tomandlová, Marie - Dostálová, Zuzana - Vašků, Anna
PY  - 2012
TI  - Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth
JF  - Diabetes Research and Clinical Practice
VL  - 96
IS  - 3
SP  - 355-361
EP  - 355-361
PB  - Elsevier Ireland
SN  - 01688227
KW  - visfatin
KW  - breast milk
KW  - adiposity
KW  - infant weight
N2  - Visfatin is a recently identified adipokine with numerous metabolic and immunoregulatory properties that has been implicated in the regulation of the white adipose tissue (WAT) and significant changes in visfatin levels were reported during pregnancy. The aim of the study was to investigate dynamics of visfatin levels in maternal serum and human breast milk during a 180-d period after the delivery. Breast milk and venous blood samples were obtained from 24 healthy lactating women with uncomplicated, physiological pregnancy and appropriate- for-gestational age neonates and serum–milk sample duos were collected at the time of birth, at the 1–3, 12–14, 28–30, 88–90 and 178–180 postpartum. Our study demonstrates that (1) visfatin is abundantly secreted into breast milk in humans, reaching approx. 100x higher concentrations compared to maternal serum; (2) visfatin concentrations in maternal serum show significant variations after the delivery and (3) visfatin concentration in colostrum could be used for prediction of the subsequent weight development (less/more severe weight loss during first 3 days after the birth) of the infant. Our data suggest that visfatin could play an important role in regulation of adiposity of the infatn after the birth.
ER  -

BIENERTOVÁ VAŠKŮ, Julie; Petr BIENERT; Filip ZLÁMAL; Josef TOMANDL; Marie TOMANDLOVÁ; Zuzana DOSTÁLOVÁ a Anna VAŠKŮ. Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth. \textit{Diabetes Research and Clinical Practice}. Ireland: Elsevier Ireland, 2012, roč.~96, č.~3, s.~355-361. ISSN~0168-8227. Dostupné z: https://doi.org/10.1016/j.diabres.2011.06.009.

Přehled o publikaci